Romina Deza Ponzio

Dr. Romina Deza Ponzio

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in NeuroToxicology
Verified
Journal Article
Open access
RPRomina Deza Ponzio
Romina Deza Ponzio
MHMacarena Lorena Herrera
Macarena Lorena Herrera
MBMaria Jose Bellini
Maria Jose Bellini
Miriam Beatriz VirgoliniMiriam Beatriz Virgolini
Miriam Beatriz Virgolini
CHClaudia Hereñu
Claudia Hereñu
Growing body of evidence suggests that mitochondrial dysfunctions and resultant oxidative stress are likely responsible for many neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD). Aldehyde dehydrogenase (ALDH) superfamily plays a crucial role in several biological processes including development and detoxification pathways in the organism. In particular, ALDH2 is crucial in the oxidative metabolism of toxic aldehydes in the brain, such as catecholaminergic metabolites (DOPAL and DOPEGAL) and the principal product of lipid peroxidation process 4-HNE. This review aims to deepen the current knowledge regarding to ALDH2 function and its relation with brain-damaging processes that increase the risk to develop neurodegenerative disorders. We focused on relevant literature of what is currently known at molecular and cellular levels in experimental models of these pathologies. The understanding of ALDH2 contributions could be a potential target in new therapeutic approaches for PD and AD due to its crucial role in mitochondrial normal function maintenance that protects against neurotoxicity.

1 December 2016 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
PBPamela Soledad Bustos
Pamela Soledad Bustos
RPRomina Deza Ponzio
Romina Deza Ponzio
PPPaulina L. Páez
Paulina L. Páez
IAInes Albesa
Ines Albesa
JCJosé Luis Cabrera
José Luis Cabrera
MOMaría Gabriela Ortega
María Gabriela Ortega

3 August 2023 in Toxics
Verified
Journal Article
Open access
PDF file
AJAirton Cunha Martins Jr.
Airton Cunha Martins Jr.
BVBeatriz Ferrer Villahoz
Beatriz Ferrer Villahoz
TATinkov Alexey
Tinkov Alexey
Sam CaitoSam Caito
Sam Caito
RPRomina Deza Ponzio
Romina Deza Ponzio
Michael AschnerMichael Aschner
Michael Aschner
Metabolic syndrome (MetS) is an important public health issue that affects millions of people around the world and is growing to pandemic-like proportions. This syndrome is defined by the World Health Organization (WHO) as a pathologic condition characterized by abdominal obesity, insulin resistance, hypertension, and hyperlipidemia. Moreover, the etiology of MetS is multifactorial, involving many environmental factors, including toxicant exposures. Several studies have associated MetS with heavy metals exposure, which is the focus of this review. Environmental and/or occupational exposure to heavy metals are a major risk, contributing to the development of chronic diseases. Of particular note, toxic metals such as mercury, lead, and cadmium may contribute to the development of MetS by altering oxidative stress, IL-6 signaling, apoptosis, altered lipoprotein metabolism, fluid shear stress and atherosclerosis, and other mechanisms. In this review, we discuss the known and potential roles of heavy metals in MetS etiology as well as potential targeted pathways that are associated with MetS. Furthermore, we describe how new approaches involving proteomic and transcriptome analysis, as well as bioinformatic tools, may help bring about an understanding of the involvement of heavy metals and metalloids in MetS.

1 August 2018 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
PBPamela Soledad Bustos
Pamela Soledad Bustos
RPRomina Deza Ponzio
Romina Deza Ponzio
PPPaulina Laura Páez
Paulina Laura Páez
JCJosé Luis Cabrera
José Luis Cabrera
MVMiriam Beatriz Virgolini
Miriam Beatriz Virgolini
MOMaría Gabriela Ortega
María Gabriela Ortega

14 December 2023 in Cells
Verified
Journal Article
Open access
PDF file
HCHong Cheng
Hong Cheng
BVBeatriz Ferrer Villahoz
Beatriz Ferrer Villahoz
RPRomina Deza Ponzio
Romina Deza Ponzio
Michael AschnerMichael Aschner
Michael Aschner
Pan ChenPan Chen
Pan Chen
Manganese (Mn) is an essential trace element, but insufficient or excessive bodily amounts can induce neurotoxicity. Mn can directly increase neuronal insulin and activate insulin-like growth factor (IGF) receptors. As an important cofactor, Mn regulates signaling pathways involved in various enzymes. The IGF signaling pathway plays a protective role in the neurotoxicity of Mn, reducing apoptosis in neurons and motor deficits by regulating its downstream protein kinase B (Akt), mitogen-activated protein kinase (MAPK), and mammalian target of rapamycin (mTOR). In recent years, some new mechanisms related to neuroinflammation have been shown to also play an important role in Mn-induced neurotoxicity. For example, DNA-sensing receptor cyclic GMP–AMP synthase (cCAS) and its downstream signal efficient interferon gene stimulator (STING), NOD-like receptor family pyrin domain containing 3(NLRP3)-pro-caspase1, cleaves to the active form capase1 (CASP1), nuclear factor κB (NF-κB), sirtuin (SIRT), and Janus kinase (JAK) and signal transducers and activators of the transcription (STAT) signaling pathway. Moreover, autophagy, as an important downstream protein degradation pathway, determines the fate of neurons and is regulated by these upstream signals. Interestingly, the role of autophagy in Mn-induced neurotoxicity is bidirectional. This review summarizes the molecular signaling pathways of Mn-induced neurotoxicity, providing insight for further understanding of the mechanisms of Mn.

1 February 2017 in Alcohol
Verified
Journal Article
Closed access
MMMara Soledad Mattalloni
Mara Soledad Mattalloni
RPRomina Deza Ponzio
Romina Deza Ponzio
PAPaula Alejandra Albrecht
Paula Alejandra Albrecht
LCLiliana Marina Cancela
Liliana Marina Cancela
Miriam Beatriz VirgoliniMiriam Beatriz Virgolini
Miriam Beatriz Virgolini